Literature DB >> 29281001

Genome U-Plot: a whole genome visualization.

Athanasios Gaitatzes1,2, Sarah H Johnson1, James B Smadbeck1, George Vasmatzis1.   

Abstract

Motivation: The ability to produce and analyze whole genome sequencing (WGS) data from samples with structural variations (SV) generated the need to visualize such abnormalities in simplified plots. Conventional two-dimensional representations of WGS data frequently use either circular or linear layouts. There are several diverse advantages regarding both these representations, but their major disadvantage is that they do not use the two-dimensional space very efficiently. We propose a layout, termed the Genome U-Plot, which spreads the chromosomes on a two-dimensional surface and essentially quadruples the spatial resolution. We present the Genome U-Plot for producing clear and intuitive graphs that allows researchers to generate novel insights and hypotheses by visualizing SVs such as deletions, amplifications, and chromoanagenesis events. The main features of the Genome U-Plot are its layered layout, its high spatial resolution and its improved aesthetic qualities. We compare conventional visualization schemas with the Genome U-Plot using visualization metrics such as number of line crossings and crossing angle resolution measures. Based on our metrics, we improve the readability of the resulting graph by at least 2-fold, making apparent important features and making it easy to identify important genomic changes.
Results: A whole genome visualization tool with high spatial resolution and improved aesthetic qualities. Availability and implementation: An implementation and documentation of the Genome U-Plot is publicly available at https://github.com/gaitat/GenomeUPlot. Contact: vasmatzis.george@mayo.edu. Supplementary information: Supplementary data are available at Bioinformatics online.

Entities:  

Mesh:

Year:  2018        PMID: 29281001     DOI: 10.1093/bioinformatics/btx829

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  15 in total

1.  Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma.

Authors:  Aaron S Mansfield; Tobias Peikert; James B Smadbeck; Julia B M Udell; Enrique Garcia-Rivera; Laura Elsbernd; Courtney L Erskine; Virginia P Van Keulen; Farhad Kosari; Stephen J Murphy; Hongzheng Ren; Vishnu V Serla; Janet L Schaefer Klein; Giannoula Karagouga; Faye R Harris; Carlos Sosa; Sarah H Johnson; Wendy Nevala; Svetomir N Markovic; Aaron O Bungum; Eric S Edell; Haidong Dong; John C Cheville; Marie Christine Aubry; Jin Jen; George Vasmatzis
Journal:  J Thorac Oncol       Date:  2018-10-10       Impact factor: 15.609

2.  Characterization of unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children's Oncology Group.

Authors:  Alaa Koleilat; James B Smadbeck; Cinthya J Zepeda-Mendoza; Cynthia M Williamson; Beth A Pitel; Crystal L Golden; Xinjie Xu; Patricia T Greipp; Rhett P Ketterling; Nicole L Hoppman; Jess F Peterson; Christine J Harrison; Yassmine M N Akkari; Karen D Tsuchiya; Mary Shago; Linda B Baughn
Journal:  Genes Chromosomes Cancer       Date:  2022-07-19       Impact factor: 4.263

3.  Copy number variant analysis using genome-wide mate-pair sequencing.

Authors:  James B Smadbeck; Sarah H Johnson; Stephanie A Smoley; Athanasios Gaitatzes; Travis M Drucker; Roman M Zenka; Farhad Kosari; Stephen J Murphy; Nicole Hoppman; Umut Aypar; William R Sukov; Robert B Jenkins; Hutton M Kearney; Andrew L Feldman; George Vasmatzis
Journal:  Genes Chromosomes Cancer       Date:  2018-07-30       Impact factor: 5.006

4.  Frequently rearranged and overexpressed δ-catenin is responsible for low sensitivity of prostate cancer cells to androgen receptor and β-catenin antagonists.

Authors:  Piyan Zhang; Janet Schaefer-Klein; John C Cheville; George Vasmatzis; Irina V Kovtun
Journal:  Oncotarget       Date:  2018-05-11

5.  Targeting HER2 in patient-derived xenograft ovarian cancer models sensitizes tumors to chemotherapy.

Authors:  Faye R Harris; Piyan Zhang; Lin Yang; Xiaonan Hou; Konstantinos Leventakos; Saravut J Weroha; George Vasmatzis; Irina V Kovtun
Journal:  Mol Oncol       Date:  2018-12-21       Impact factor: 6.603

6.  Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing.

Authors:  Alan H Bryce; Jan B Egan; James B Smadbeck; Sarah H Johnson; Stephen J Murphy; Faye R Harris; Geoffrey C Halling; Simone B S P Terra; John Cheville; Lance Pagliaro; Brad Leibovich; Brian A Costello; George Vasmatzis
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

7.  The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma.

Authors:  Neeraj Sharma; James B Smadbeck; Nadine Abdallah; Cinthya Zepeda-Mendoza; Moritz Binder; Kathryn E Pearce; Yan W Asmann; Jess F Peterson; Rhett P Ketterling; Patricia T Greipp; P Leif Bergsagel; S Vincent Rajkumar; Shaji K Kumar; Linda B Baughn
Journal:  Clin Cancer Res       Date:  2021-10-01       Impact factor: 12.531

8.  Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer.

Authors:  Tommaso Grassi; Faye R Harris; James B Smadbeck; Stephen J Murphy; Matthew S Block; Francesco Multinu; Janet L Schaefer Klein; Piyan Zhang; Giannoula Karagouga; Minetta C Liu; Alyssa Larish; Maureen A Lemens; Marla Kay S Sommerfield; Serena Cappuccio; John C Cheville; George Vasmatzis; Andrea Mariani
Journal:  PLoS One       Date:  2021-06-10       Impact factor: 3.240

9.  Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2+ breast cancer samples.

Authors:  George Vasmatzis; Xue Wang; James B Smadbeck; Stephen J Murphy; Katherine B Geiersbach; Sarah H Johnson; Athanasios G Gaitatzes; Yan W Asmann; Farhad Kosari; Mitesh J Borad; Daniel J Serie; Sarah A McLaughlin; Jennifer M Kachergus; Brian M Necela; E Aubrey Thompson
Journal:  BMC Cancer       Date:  2018-07-13       Impact factor: 4.430

10.  Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine.

Authors:  Jennifer L Leiting; Stephen J Murphy; John R Bergquist; Matthew C Hernandez; Tommy Ivanics; Amro M Abdelrahman; Lin Yang; Isaac Lynch; James B Smadbeck; Sean P Cleary; David M Nagorney; Michael S Torbenson; Rondell P Graham; Lewis R Roberts; Gregory J Gores; Rory L Smoot; Mark J Truty
Journal:  JHEP Rep       Date:  2020-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.